Artificial Joints Market Research Insights:
An Artificial joint is a plastic or metallic part (also known as a prosthesis) that is surgically implanted into a tissue as a replacement for a natural joint. A joint replacement surgery or replacement arthroplasty involves the process of replacing an arthritic or dysfunctional joint surface with an orthopedic prosthesis. Artificial joints emulate a natural joint’s shape and movement. They are generally used to replace arthritic hip and knee joints, as bone cement to fix limb and spine fractures, and as artificial bones used in bone grafting and bone tumors. Artificial joints must be tested before implantation to ensure their wear resistance, high corrosion resistance, durability, and biocompatibility.
Innovative robotic technologies have emerged in joint replacement surgery, enabling surgeons to personalize surgical procedures. For instance, the Tennessee-based Parkwest Medical Center is one of the first hospitals in the U.S. to offer robotic-assisted knee replacements. Robotic knee replacements are designed to relieve joint degeneration pain caused by osteoarthritis, and this technology improves patient outcomes in terms of reduced medical risks and faster recovery. The global artificial joints market is poised to witness substantial growth in the years to come. The rapidly growing geriatric population, surging prevalence of chronic arthritis, osteoarthritis, and rheumatoid arthritis, increasing orthopedic procedures, the escalating rate of obesity worldwide, introduction of advanced medical technologies, and the availability of high-quality joint prostheses with enhanced functionality are some of the fundamental parameters influencing the global market expansion. However, high costs of artificial joints, specific complications associated with their use in joint replacement surgeries, and the lack of reimbursement policies are the factors likely to impede the market growth to some extent.
Among the leading regions in the global artificial joints market, North America is the most dominant region with the largest market share. The regional market is expected to maintain its dominance over the coming years, owing to increasing joint replacement procedures, growing prevalence of obesity, and the growing aging population in the region. As estimated by the American Academy of Orthopedic Surgeons (AAOS), nearly 2.4 million people in the U.S. would be diagnosed with a severe spine condition called lumbar spinal stenosis (LSS) by 2021. The established companies operating across the global artificial joints market include DePuy Synthes, ConforMIS, Biomet, Inc., Aesculap AG, Exactech, Inc., NuVasive, Inc., DJO Global, Inc., JRI Orthopaedics, SAMO, Medtronic, Inc., Globus Medical, AK Medical, Stryker Corp., Arthrex, Smith & Nephew, and Zimmer Holdings.
DePuy Synthes, the leading U.S.-based medical device manufacturer, acquired by Johnson & Johnson in 1998, had introduced the ATTUNE Cementless Knee System in 2019. The product is an addition to the company’s ATTUNE Knee artificial joints range. According to the company, the demand for cementless knee replacement is rising globally, especially among the younger population who have a more active lifestyle. Moreover, the renowned U.S.-based knee & hip implants manufacturer, ConforMIS, launched its new Cordera Hip System in September 2020. The product is an uncemented hip replacement made of femoral and acetabular components and is used in hip replacement surgeries due to severe osteoarthritis, traumatic arthritis, or congenital hip dysplasia.
Read full Press release, visit@ https://www.reportsanddata.com/press-release/global-artificial-joints-market
No comments:
Post a Comment